BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waziry R, Grebely J, Amin J, Alavi M, Hajarizadeh B, George J, Matthews GV, Law M, Dore GJ. Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014). Hepatol Commun 2017;1:736-47. [PMID: 29404490 DOI: 10.1002/hep4.1073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Dore GJ, Hajarizadeh B. Elimination of Hepatitis C Virus in Australia. Infectious Disease Clinics of North America 2018;32:269-79. [DOI: 10.1016/j.idc.2018.02.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
2 Wigg AJ, Narayana SK, Hartel G, Medlin L, Pratt G, Powell EE, Clark P, Davies J, Campbell K, Toombs M, Larkin M, Valery PC. Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia. EClinicalMedicine 2021;36:100919. [PMID: 34142069 DOI: 10.1016/j.eclinm.2021.100919] [Reference Citation Analysis]
3 Kwon JA, Dore GJ, Grebely J, Hajarizadeh B, Guy R, Cunningham EB, Power C, Estes C, Razavi H, Gray RT; HCV Estimates and Projections Reference Group. Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study. J Viral Hepat 2019;26:83-92. [PMID: 30267593 DOI: 10.1111/jvh.13013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
4 Lockart I, Hajarizadeh B, Buckley N, Davison S, Prakoso E, Levy MT, George J, Dore GJ, Danta M. All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy. J Gastroenterol Hepatol 2021. [PMID: 34520088 DOI: 10.1111/jgh.15687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kou Y, Yan X, Liu Q, Wei X, Zhang B, Li X, Pan W, Kong F, Wang Y, Zheng K, Tang R. HBV upregulates AP-1 complex subunit mu-1 expression via the JNK pathway to promote proliferation of liver cancer cells. Oncol Lett 2019;18:456-64. [PMID: 31289517 DOI: 10.3892/ol.2019.10291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Sun Y, Pang B, Wang Y, Xiao J, Jiang D. Baohuoside I Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Apoptosis Signaling and NF-kB Pathway. Chem Biodivers 2021;18:e2100063. [PMID: 33904248 DOI: 10.1002/cbdv.202100063] [Reference Citation Analysis]